Skip to main content

Effect of peroxovanadate compound on phenylalanine hydroxylase gene expression

Biological Trace Element Research volume 74, pages 237–244 (2000)Cite this article

Abstract

Vanadium, a trace element in human cells and regarded as an essential nutrient, plays an active role in all tissues. It is known that peroxovanadate-nicotinic acid (POV), a complex compound of vanadium, can decrease hyperglycemia; however, its biochemical mechanism remains unclear. The object of the present study is to explore the hypoglycemia mechanism of POV at gene molecular levels. Rats rendered diabetic with streptozotocin were treated with POV. Total RNA was isolated from rat liver, and phenylalanine hydroxylase (PAH) mRNA abundance was determined by reverse transcriptase-polymerase chain reaction. PAH activity, blood glucose, and lipid levels were measured. Significantly increased hepatic PAH activity and corresponding mRNA with concomitant hyperglycemia and hyperlipemia were found in diabetic rats. These levels returned to normal after POV treatment and accompanied by negative glucosuria, normoglycemia, and normolipemia. The results from the current study indicates one of the mechanisms of POV action is to inhibit PAH gene expression and PAH activity, thus decreasing gluconeogenesis and hyperglycemia. At the same time, POV is able to promote diabetic recovery by lowering hyperlipemia.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. C. Djordjevic and B C. Puryear, Preparation, spectroscopic properties and characterization of novel peroxo complexes of vanadium (V) and molybdenum (VI) with nicotinic acid and nicotinic acid N-oxide, Inorg. Chem. 27, 2926–2931 (1988).

    Article  CAS  Google Scholar 

  2. R. K. Murray, Harper’s Biochemistry, 23rd ed, Prentice-Hall Canadian Inc., Toronto, pp. 312–315 (1993).

    Google Scholar 

  3. D. S. Taylor, The effect of streptozocin-induced diabetes on phenylalanine hydroxylase expression in rat liver, Biochem. J. 264, 185–90 (1989).

    PubMed  CAS  Google Scholar 

  4. D. Zhu and B. J. Yu, Quantitative glomerular morphology of the normal and diabetic rat kidney. Acad. J. Sun Yat-Sen Univ. Med. Sci. 11, 38–40 (1990).

    Google Scholar 

  5. S. L. C. Woo, S. S. Gillan, and L. I. Woolf, The isolation and properties of phenylalanine hydroxylase from human liver, Biochem. J. 139, 741–743 (1974).

    PubMed  CAS  Google Scholar 

  6. J. E. Ayling, W. D. Pirso, and J. M. Aijanabi, Kidney phenylalanine hydronylase from man and rat, Biochemistry 13, 78–80 (1974).

    PubMed  Article  CAS  Google Scholar 

  7. D. N. Rao and S. Kaufman, Purification and state of activation of rat kidney phenylalanine hydroxylase, J. Biochem. 261, 8866–8869 (1986).

    CAS  Google Scholar 

  8. Y. L. Wang and B. J. Yu, Measurement and assessment of phenylalanine hydroxylase activity, Bull. South-China Univ. Technol. 68(Suppl.) 117–119 (1996).

    Google Scholar 

  9. P. Chomczynski, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162, 156–159 (1987).

    PubMed  Article  CAS  Google Scholar 

  10. B. H. Xu and R. H. Tang, Trace Elements in Life Sciences, Chinese Calculating Press, Beijing, pp. 326–350 (1992).

    Google Scholar 

  11. E. J. Underwood, Trace elements in Human and Animal Nutrition, 4th ed., Academic, New York, p. 250 (1977).

    Google Scholar 

  12. A. Green, The insulin-like effect of sodium vanadate on adipocyte glucose transport is mediated at a post-insulin receptor level, Biochemistry 238, 663–665 (1986).

    CAS  Google Scholar 

  13. Y. Shechter, Insulin-mimetic effects of vanadate, Diabetes 39, 1–6 (1990).

    PubMed  Article  CAS  Google Scholar 

  14. Y. L. Wang and B. J. Yu, Effect of peroxovanadate compound on phodphoenolpyruvate carboxykinase gene expression and lipid metabolism in diabetic rats, Drugs Exp. Clin. Res. XXIII(3/4), 111–115 (1997).

    Google Scholar 

  15. S. M. Brichard, B. Desbuquois, and J. Girard, Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2, Mol. Cell. Endocrinol. 91(1–2), 91–97 (1993).

    PubMed  Article  CAS  Google Scholar 

  16. A. Valera, G. J. E. Rodriguez, and F. Bosch, Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats, J. Clin. Invest. 92(1), 4–11 (1993).

    PubMed  CAS  Article  Google Scholar 

  17. I. McDowall, The effect of vanadate on selected mRNA abundance in streptozotocin-diabetic rat liver, Biochem. Soc. Trans. 21, 387s (1993).

    Google Scholar 

Download references

Author information

Affiliations

  1. Endocrine Research Unit, Sun Yat-Sen University of Medical Sciences, 510089, Guangzhou, People’s Republic of China

    Yan Lin Wang & Binjie Yu

Authors
  1. Yan Lin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Binjie Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wang, Y.L., Yu, B. Effect of peroxovanadate compound on phenylalanine hydroxylase gene expression. Biol Trace Elem Res 74, 237–244 (2000). https://doi.org/10.1385/BTER:74:3:237

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/BTER:74:3:237

Index Entries

  • Peroxovanadate-nicotinic acid
  • diabetes
  • phenylalanine hydroxylase